We observed a clear difference in BCR progression, free survival analysis between the fusion positive vs. negative tumours with a highly significant logrank p (<0.0001) for the PDE4D7 categories in the presence of the rearranged TMPRSS2-ERG gene fusion (Figure 1(a)). The gene discussed is ERG; the disease is neoplasm.